Glenmark Pharmaceuticals
GLENMARK.NS
#2705
Rank
A$7.84 B
Marketcap
$27.80
Share price
-2.90%
Change (1 day)
103.37%
Change (1 year)

Glenmark Pharmaceuticals (GLENMARK.NS) - Total debt

Total debt on the balance sheet as of March 2024 : A$0.22 Billion

According to Glenmark Pharmaceuticals 's latest financial reports the company's total debt is A$0.22 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Glenmark Pharmaceuticals - Total debt on balance sheet (from 2012 to 2024)

Total debt by year

Year Total debt Change
2023-03-31A$0.83 B20.49%
2022-03-31A$0.69 B-21.94%
2021-03-31A$0.89 B-19.98%
2020-03-31A$1.11 B23.32%
2019-03-31A$0.90 B-2.52%
2018-03-31A$0.92 B-2.62%
2017-03-31A$0.95 B21.42%
2016-03-31A$0.78 B-1.19%
2015-03-31A$0.79 B34.64%
2014-03-31A$0.58 B20.56%
2013-03-31A$0.48 B15%
2012-03-31A$0.42 B-7.16%
2011-03-31A$0.45 B0.5%
2010-03-31A$0.45 B-23.55%
2009-03-31A$0.59 B119.29%
2008-03-31A$0.27 B1.24%
2007-03-31A$0.26 B14.76%
2006-03-31A$0.23 B80.25%
2005-03-31A$0.12 B268.97%
2004-03-31A$35.18 M